US Patent Issued to Cedars-Sinai Medical Center on June 24 for "Methods for targeting the immune checkpoint PD1 pathway for treating pulmonary fibrosis" (California Inventors)

ALEXANDRIA, Va., June 25 -- United States Patent no. 12,338,283, issued on June 24, was assigned to Cedars-Sinai Medical Center (Los Angeles).

"Methods for targeting the immune checkpoint PD1 pathway for treating pulmonary fibrosis" was invented by Paul W. Noble (Beverly Hills, Calif.), Dianhua Jiang (Encion, Calif.) and Carol Jiurong Liang (Encino, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to methods for treating or preventing progressive pulmonary fibrosis in a subject."

The patent was filed on June 13, 2023, under Application No. 18/333,869.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&...